|
1177
|
rAT and rLukS-PV
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Toxoid
|
Uniformed Services University of the Health Sciences
|
Clinical - Phase 1, Phase 2
|
NA
|
NA
|
NCT01011335
|
|
1178
|
SA4AG
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Polysaccharide
|
Pfizer
|
Clinical - Terminated
|
Intramuscular
|
27916408
|
NCT02388165
|
|
1179
|
SA3Ag
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Polysaccharide
|
Pfizer
|
Clinical - Phase 1
|
Intramuscular
|
25707693
|
NCT01018641
|
|
1180
|
NDV-3
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Recombinant
|
NovaDigm Therapeutics, Inc.
|
Clinical - Phase 1
|
Intramuscular
|
25489065
|
NCT01273922
|
|
1181
|
StaphVAX
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Conjugate
|
Nabi Biopharmaceuticals
|
Clinical - Failed
|
NA
|
12054071
|
NCT00071214
|
|
1182
|
V710
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Recombinant
|
Merck Sharp & Dohme Corp
|
Clinical - Failed
|
Intramuscular
|
25483690
|
NCT00518687
|
|
1183
|
Pentastaph
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Conjugate
|
NABI/GSK
|
Clinical - Failed
|
NA
|
21501445
|
NA
|